Cargando…
Platelet-targeted thrombolysis for treatment of acute ischemic stroke
Thrombolysis with tissue-type plasminogen activator (tPA) remains the main treatment for acute ischemic stroke. Nevertheless, tPA intervention is limited by a short therapeutic window, low recanalization rates, and a risk of intracranial hemorrhage (ICH), highlighting the clinical demand for improve...
Autores principales: | Palazzolo, Jason S., Ale, Anukreity, Ho, Heidi, Jagdale, Shweta, Broughton, Brad R. S., Medcalf, Robert L., Wright, David K., Alt, Karen, Hagemeyer, Christoph E., Niego, Be’eri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984306/ https://www.ncbi.nlm.nih.gov/pubmed/35482909 http://dx.doi.org/10.1182/bloodadvances.2021006691 |
Ejemplares similares
-
Development of a carotid artery thrombolysis stroke model in mice
por: Maclean, Jessica A. A., et al.
Publicado: (2022) -
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
por: Fanikos, John, et al.
Publicado: (2021) -
PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke
por: Dhanesha, Nirav, et al.
Publicado: (2022) -
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia
por: Karnes, Jason H., et al.
Publicado: (2022) -
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study
por: Kristiansen, Marie Hvelplund, et al.
Publicado: (2023)